Oaktree Specialty Lending Corporation is a business development company specializing in investments in middle market, bridge financing, first and second lien debt financing, mezzanine debt, senior and junior secured debt, expansions, sponsor-led acquisitions, and management buyouts in small and mid-sized companies. The fund seeks to invest in education services, business services, retail and consumer, healthcare, manufacturing, food and restaurants, construction and engineering, and media and advertising sectors.
Read More…
Industry, Sector and Symbol
Industry Personal credit institutions
Sub-IndustryAsset Management & Custody Banks
SectorFinance
Phone213-830-6300
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$138.72 million
Profitability
Miscellaneous
EmployeesN/A
Next Earnings Date12/5/2019 (Estimated)
OptionableOptionable
Oaktree Specialty Lending (NASDAQ:OCSL) Frequently Asked Questions
What is Oaktree Specialty Lending's stock symbol?
Oaktree Specialty Lending trades on the NASDAQ under the ticker symbol "OCSL."
How often does Oaktree Specialty Lending pay dividends? What is the dividend yield for Oaktree Specialty Lending?
Oaktree Specialty Lending announced a quarterly dividend on Wednesday, August 7th. Shareholders of record on Friday, September 13th will be given a dividend of $0.095 per share on Monday, September 30th. This represents a $0.38 annualized dividend and a yield of 7.22%. The ex-dividend date of this dividend is Thursday, September 12th. View Oaktree Specialty Lending's Dividend History.
How were Oaktree Specialty Lending's earnings last quarter?
Oaktree Specialty Lending Corp (NASDAQ:OCSL) announced its quarterly earnings data on Wednesday, August, 7th. The credit services provider reported $0.12 EPS for the quarter, meeting the consensus estimate of $0.12. The credit services provider earned $36.67 million during the quarter, compared to analyst estimates of $39.57 million. Oaktree Specialty Lending had a net margin of 96.11% and a return on equity of 7.66%. View Oaktree Specialty Lending's Earnings History.
When is Oaktree Specialty Lending's next earnings date?
What price target have analysts set for OCSL?
3 equities research analysts have issued 1 year price objectives for Oaktree Specialty Lending's stock. Their forecasts range from $5.75 to $7.00. On average, they expect Oaktree Specialty Lending's share price to reach $6.3750 in the next twelve months. This suggests a possible upside of 21.2% from the stock's current price. View Analyst Price Targets for Oaktree Specialty Lending.
What is the consensus analysts' recommendation for Oaktree Specialty Lending?
3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Oaktree Specialty Lending in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Oaktree Specialty Lending.
What are Wall Street analysts saying about Oaktree Specialty Lending stock?
Here are some recent quotes from research analysts about Oaktree Specialty Lending stock:
- 1. According to Zacks Investment Research, "Oaktree Specialty Lending Corporation is a specialty finance company. It provides customized, one-stop credit solutions to companies with limited access to public or syndicated capital markets. The company generates current income and capital appreciation by providing companies with flexible and innovative financing solutions including first and second lien loans, unsecured and mezzanine loans and preferred equity. Oaktree Specialty Lending Corporation, formerly known as Fifth Street Finance Corp., is based in CA, United States. " (9/10/2019)
- 2. National Securities analysts commented, "▪ OCSL’s NAV/share was up 5.9% sequentially Q/Q to $6.55 from $6.19. We had forecasted NAV/share to finish 3/31/19 at $6.42. The sale of Maverick above prior quarter marks and reversal of technical marks due to spread compression in the quarter gave NAV a significant lift.
▪ Oaktree still has $159.5mm of inherited non-accruals at cost and we expect these to be exited over the course of the next four quarters, with sales proceeds recycled into direct originations which should boost total effective yield and be positive for earnings. Total non-accruals are marked at 54% of cost compared to 63% Q/Q largely from the write-downs of Dominion Diagnostics and Cenegenics.
▪ Oaktree is seeking shareholder approval for reduced asset coverage. With Brookfield acquiring a 63% economic interest, it doesn’t currently impact the investment advisory agreement but at some point it may down the road and thus Oaktree is seeking to have shareholders vote on the investment advisory agreement along with reduced asset coverage. The company will lower fees to 100 bps on assets purchased at over 1.00x D/E but is not changing their targeted leverage range.
▪ We would only expect Oaktree to exceed 1.00x D/E if there is severe and sustained market dislocation, as the broader Oaktree platform is largely opportunistic and countercyclical in how it operates. Until and unless that occurs, we think there is still meaningful room for earnings growth from disposing of the $156mm of non-income producing investments and $32mm of BSL with spreads under 400 bps over LIBOR. The rotation out of these assets and into proprietary originations, opportunistic BSL purchases, and the Kemper JV (whose assets grew to $347mm from $310mm Q/Q) should serve to augment effective yield and thus NIM in F2019.
▪ We are revising our fiscal 2019 NII/share estimate to $0.51 from $0.50 and our fiscal 2020 NII/share estimate to $0.54 from $0.55." (5/13/2019)
Has Oaktree Specialty Lending been receiving favorable news coverage?
Media stories about OCSL stock have been trending somewhat positive recently, InfoTrie Sentiment Analysis reports. The research firm scores the sentiment of press coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Oaktree Specialty Lending earned a news sentiment score of 0.9 on InfoTrie's scale. They also assigned press coverage about the credit services provider a news buzz of 1.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View News Stories for Oaktree Specialty Lending.
Are investors shorting Oaktree Specialty Lending?
Oaktree Specialty Lending saw a increase in short interest in the month of August. As of August 31st, there was short interest totalling 260,900 shares, an increase of 5.6% from the July 31st total of 247,000 shares. Based on an average daily volume of 353,300 shares, the days-to-cover ratio is presently 0.7 days. Approximately 0.2% of the company's stock are sold short. View Oaktree Specialty Lending's Current Options Chain.
Who are some of Oaktree Specialty Lending's key competitors?
What other stocks do shareholders of Oaktree Specialty Lending own?
Who are Oaktree Specialty Lending's key executives?
Oaktree Specialty Lending's management team includes the folowing people:
- Mr. Sandeep Kumar Khorana, Managing Director of Origination (Age 46)
- Mr. Edgar Lee, Chief Exec. Officer & Chief Investment Officer (Age 43)
- Mr. Mel Carlisle CPA, Chief Financial Officer & Treasurer (Age 50)
- Mr. Mathew M. Pendo, Chief Operating Officer (Age 55)
- Mr. Michael Mosticchio, Investor Relations
Who are Oaktree Specialty Lending's major shareholders?
Oaktree Specialty Lending's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Bruni J V & Co. Co. (2.83%), LSV Asset Management (1.63%), Citadel Advisors LLC (1.10%), Bayview Asset Management LLC (1.04%), Investment Management of Virginia LLC (0.93%) and Greenwich Investment Management Inc. (0.87%). Company insiders that own Oaktree Specialty Lending stock include Bernard D Berman, Bruce Zimmerman, Craig A Jacobson, Deborah Ann Gero, John Frank, Leonard M Tannenbaum, Marc Gamsin, Mathew Pendo, Melvin Carlisle, Oaktree Capital Management Lp and Richard Ruben. View Institutional Ownership Trends for Oaktree Specialty Lending.
Which major investors are selling Oaktree Specialty Lending stock?
OCSL stock was sold by a variety of institutional investors in the last quarter, including Arnhold LLC, Bayview Asset Management LLC, Systematic Financial Management LP, RMB Capital Management LLC, Bank of New York Mellon Corp, Wells Fargo & Company MN, GSA Capital Partners LLP and Invesco Ltd.. View Insider Buying and Selling for Oaktree Specialty Lending.
Which major investors are buying Oaktree Specialty Lending stock?
OCSL stock was bought by a variety of institutional investors in the last quarter, including Centaurus Financial Inc., Keeley Teton Advisors LLC, Virtus ETF Advisers LLC, Cliffwater LLC, Mckinley Capital Management LLC Delaware, JPMorgan Chase & Co., BlackRock Inc. and Greenwich Investment Management Inc.. Company insiders that have bought Oaktree Specialty Lending stock in the last two years include Bruce Zimmerman, Craig A Jacobson, Deborah Ann Gero, John Frank, Marc Gamsin, Mathew Pendo, Melvin Carlisle, Oaktree Capital Management Lp and Richard Ruben. View Insider Buying and Selling for Oaktree Specialty Lending.
How do I buy shares of Oaktree Specialty Lending?
Shares of OCSL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Oaktree Specialty Lending's stock price today?
One share of OCSL stock can currently be purchased for approximately $5.26.
How big of a company is Oaktree Specialty Lending?
Oaktree Specialty Lending has a market capitalization of $741.45 million and generates $138.72 million in revenue each year. The credit services provider earns $46.76 million in net income (profit) each year or $0.43 on an earnings per share basis. View Additional Information About Oaktree Specialty Lending.
What is Oaktree Specialty Lending's official website?
How can I contact Oaktree Specialty Lending?
Oaktree Specialty Lending's mailing address is 333 SOUTH GRAND AVENUE 28TH FLOOR, LOS ANGELES CA, 90071. The credit services provider can be reached via phone at 213-830-6300 or via email at [email protected]
MarketBeat Community Rating for Oaktree Specialty Lending (NASDAQ OCSL)
MarketBeat's community ratings are surveys of what our community members think about Oaktree Specialty Lending and other stocks. Vote "Outperform" if you believe OCSL will outperform the S&P 500 over the long term. Vote "Underperform" if you believe OCSL will underperform the S&P 500 over the long term. You may vote once every thirty days.
